Integrated Transcriptomic Analysis Identifies a Six-Gene Prognostic Signature, RNA Editing Derived Neoantigens, and miRNA Regulatory Networks in Renal Cell Carcinoma
{{output}}
Background: Renal cell carcinoma (RCC) is a heterogeneous malignancy with variable outcomes and limited biomarkers for prognosis or immunotherapy response. Although mutations in VHL, SETD2, PBRM1, BAP1, FLCN, and TP53 are frequen... ...
